Market Cap 10.93M
Revenue (ttm) 0.00
Net Income (ttm) -96.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 201,749
Avg Vol 208,780
Day's Range N/A - N/A
Shares Out 39.04M
Stochastic %K 9%
Beta 3.05
Analysts Hold
Price Target $7.70

Latest News on ATHA

Athira Pharma to Participate in Upcoming June Conferences

May 29, 2024, 7:00 AM EDT - 11 months ago

Athira Pharma to Participate in Upcoming June Conferences


Athira Pharma to Participate in Upcoming May Conferences

May 2, 2024, 7:00 AM EDT - 1 year ago

Athira Pharma to Participate in Upcoming May Conferences


Athira Pharma Provides 2023 Pipeline Outlook

Jan 5, 2023, 7:00 AM EST - 2 years ago

Athira Pharma Provides 2023 Pipeline Outlook


Athira Pharma to Present at Stifel 2022 Healthcare Conference

Nov 9, 2022, 7:00 AM EST - 2 years ago

Athira Pharma to Present at Stifel 2022 Healthcare Conference